Macrophages from high-risk HLA-DQB1*0201/*0302 type 1 diabetes mellitus patients are hypersensitive to lipopolysaccharide stimulation

Scandinavian Journal of Immunology

Volumn 56, Issue 5, 2002, Pages 522-529

  Plesner, A ^a   Greenbaum, C J ^a   Gaur, L K ^a   Ernst, R K ^a   Lernmark, A ^a  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; HLA DQB1 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; CELL ACTIVATION; CELL ASSAY; CELL DIFFERENTIATION; CELL ISOLATION; CELL SECRETION; CELL STIMULATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HLA MATCHING; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOASSAY; IMMUNOSTIMULATION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; RELATIVE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 1; DINOPROSTONE; FEMALE; HETEROZYGOTE; HLA-DQ ANTIGENS; HOMOZYGOTE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036436681     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01150.x     Document Type: Article

References (48)

1. Hosszufalusi N, Chan E, Teruya M, Takei S, Granger G, Charles MA. Quantitative phenotypic and functional analyses of islet immune cells before and after diabetes onset in the BB rat. Diabetologia 1993;11:1146-54.
2. + T-cells in T-cell receptor transgenic NOD mice. Diabetes 1999;48:34-42.
3. Lernmark Å, Klöppel G, Stenger D et al. Heterogeneity of human islet pathology in newly diagnosed childhood insulin-dependent diabetes mellitus. Macrophage infiltrations and expression of HLA-DQ and glutamic acid decarboxylase. Virchows Arch 1995;425:631-40.
4. Santamaria P, Gehrz RC, Bryan MK, Barbosa JJ. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level. J Immunol 1989;143:913-22.
5. Cavallo MG, Pozzilli P, Bird C et al. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin Exp Immunol 1991;86:256-9.
6. Hussain MJ, Peakman M, Gallati H et al. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 1996;39:60-9.
7. Hussain MJ, Maher J, Warnock T, Vats A, Peakman M, Vergani D. Cytokine overproduction in healthy first degree relatives of patients with IDDM. Diabetologia 1998;41:343-9.
8. Litherland SA, Xie XT, Hutson AD et al. Aberrant prostaglandin synthase 2 expression defines an antigen- presenting cell defect for insulin-dependent diabetes mellitus. J Clin Invest 1999;104:515-23.
9. Jansen AH-DF, Hooijkaas H, Leenen PJ, Dardenne M, Drexhage HA. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 1994;43:667-75.
10. Langmuir PB, Bridgett MM, Bothwell AL, Crispe IN. Bone marrow abnormalities in the non-obese diabetic mouse. Int Immunol 1993;5:169-77.
11. Gottlieb PA, Eisenbarth GS. Mouse and man: Multiple genes and multiple autoantigens in the aetiology of type I DM and related autoimmune disorders. J Autoimmun 1996;9:277-81.
12. Buckner J, Kwok WW, Nepom B, Nepom GT. Modulation of HLA-DQ binding properties by differences in class II dimer stability and pH-dependent peptide interactions. J Immunol 1996;157:4940-5.
13. Hanninen A, Jalkanen S, Salmi M, Toikkanen S, Nikolakaros G, Simell O. Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest 1992;90:1901-10.
14. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Res Rev 1998;14:129-51.
15. Andre-Schmutz I, Hindelang C, Benoist C, Mathis D. Cellular and molecular changes accompanying the progression from insulitis to diabetes. Eur J Immunol 1999;29:245-55.
16. Held W, MacDonald HR, Weissman IL, Hess MW, Mueller C. Genes encoding tumor necrosis factor alpha and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci USA 1990;87:2239-43.
17. Ihm SH, Yoon JW. Studies on autoimmunity for initiation of beta-cell destruction. VI. Macrophages essential for development of beta-cell-specific cytotoxic effectors and insulitis in NOD mice. Diabetes 1990;39:1273-8.
18. Huang X, Yuan J, Goddard A et al. Interferon expression in the pancreata of patients with type 1 diabetes. Diabetes 1995;44:658-64.
19. Jansen A, van Hagen M, Drexhage HA. Defective maturation and function of antigen-presenting cells in type 1 diabetes. Lancet 1995;345:491-2.
20. Hanenberg H, Kolb-Bachofen V, Kantwerk-Funke G, Kolb H. Macrophage infiltration precedes and is a prerequisite for lymphocytic insulitis in pancreatic islets of pre-diabetic BB rats. Diabetologia 1989;32:126-34.
21. Jiang Z, Woda BA. Cytokine gene expression in the islets of the diabetic biobreeding/Worcester rat. J Immunol 1991;146:2990-4.
22. Nerup J, Mandrup-Poulsen T, Helqvist S et al. On the pathogenesis of IDDM. Diabetologia 1994;37:S82-9.
23. Eizirik DL, Welsh N, Hellerstrom C. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets. J Clin Endocrinol Metab 1993;76:399-403.
24. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 1996;39:1005-29.
25. Rabinovitch A, Suarez-Pinzon W, El-Sheikh A, Sorensen O, Power RF. Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: Expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM. Diabetes 1996;45:749-54.
26. Salvi GE, Yalda B, Collins JG et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997;68:127-35.
27. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, Offenbacher S. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997;24:8-16.
28. Salvi GE, Beck JD, Offenbacher S. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol 1998;3:40-50.
29. Robertson RP, Gavareski DJ, Porte Jr D, Bierman EL. Inhibition of in vivo insulin secretion by prostaglandin E1. J Clin Invest 1974;54:310-15.
30. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: A two-way relationship. Ann Periodontol 1998;3:51-61.
31. 3H recombinant human ligands. J Immunol Methods 1995;186:89-99.
32. Hampe C, Hammerle L, Bekris L et al. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes. J Clin Endocrinol Metab 2000;85:4671-9.
33. Schranz DB, Bekris L, Landin-Olsson M etal. A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS). J Immunol Methods 1998;213:87-97.
34. Darveau RP, Hancock RE. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 1983;155:831-8.
35. Caroff M, Tacken A, Szabo L. Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the 'isolated lipid A' fragment of the Bordetella pertussis endotoxin. Carbohydr Res 1988;175:273-82.
36. Plesner A, Greenbaum CJ, Lernmark Å. Low serum conditions for in vitro generation of human macrophages with macrophage-colony stimulating factor. J Immunol Methods 2001;249:53-61.
37. Serreze DV, Gaedeke JW, Leiter EH. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: Defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci USA 1993;90:9625-9.
38. Serreze DV. Autoimmune diabetes results from genetic defects manifest by antigen presenting cells. Faseb J 1993;7:1092-6.
39. Jaworski MA, Colle E, Guttmann RD. Abnormal immunoregulation in patients with insulin dependent diabetes mellitus and their healthy first degree relatives. Hum Immunol 1983;7:25-34.
40. Carrasco-Marin E, Shimizu J, Kanagawa O, Unanue ER. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol 1996;156:450-8.
41. Reizis B, Altmann DM, Cohen IR. Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: Similarity to the major histocompatibility complex class II, I-A (g) 7 protein of non-obese diabetic mice. Eur J Immunol 1997;27:2478-83.
42. Lenschow D J, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-58.
43. Like AA, Kislauskis E, Williams RM, Rossini AA. Neonatal thymectomy prevents spontaneously diabetes mellitus in the BB/W rat. Science 1982;216:644-6.
44. McKeever U, Mordes JP, Greiner DL et al. Adoptive transfer of autoimmune diabetes and thyroiditis to athymic rats. Proc Natl Acad Sci USA 1990;87:7618-22.
45. Kurosaka K, Watanabe N, Kobayashi Y. Production of proinflammatory cytokines by phorbol myristate acetate-treated THP-1 cells and monocyte-derived macrophages after phagocytosis of apoptotic CTLL-2 cells. J Immunol 1998;161:6245-9.
46. Muro M, Nakashima K, Tomioka J et al. Inhibitory effect of lipopolysaccharide on apoptotic cell death in macrophages infected with Actinobacillus actinomycetemcomitans. FEMS Microbiol Lett 1999;175:211-16.
47. Robertson RP. Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis. Diabetes 1998;47:1379-83.
48. Rothe H, Ongoren C, Martin S, Rosen P, Kolb H. Abnormal TNF-alpha production in diabetes-prone BB rats: Enhanced TNF-alpha expression and defective PGE2 feedback inhibition. Immunology 1994;81:407-13.